Less Than Half of Pregnant Women With Opioid Use Disorder Receive Meds
Medically reviewed by Drugs.com
via HealthDay FRIDAY, April 24, 2026 -- Less than half of pregnant women with opioid use disorder (OUD) receive medications for OUD (MOUD) during pregnancy, according to a study published online April 22 in Drug and Alcohol Dependence.
Silvia S. Martins, M.D., Ph.D., from the Columbia University Mailman School of Public Health in New York City, and colleagues examined prepregnancy clinical factors associated with MOUD receipt in a nationwide commercial insurance database. Pregnancies among women aged 15 to 54 years from 2016 to 2020 were identified.
Among 909,241 total pregnancies, 2,926 women (0.3 percent) had an OUD diagnosis during pregnancy or postpartum. The researchers found that 40.2 percent of the women diagnosed before or during pregnancy with OUD received MOUD. Younger age and nonmetropolitan statistical area residence were positively associated with an OUD diagnosis. Co-occurring chronic pain or concurrent substance use disorder diagnosis other than OUD were factors negatively associated with MOUD receipt during pregnancy. There was a positive association observed for having two or more mental health disorders with MOUD receipt.
"Less than half of pregnant women with OUD receive medication treatment, despite MOUD being the gold standard," Martins said in a statement. "Our findings highlight substantial missed opportunities to provide evidence-based care during pregnancy and underscore the need for targeted interventions."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-25 01:43
Read more
- Flu Vaccine Reduces Risk for Cardiovascular Events, Even With Breakthrough Infection
- Adenoidectomy, Tonsillectomy in Childhood Tied to Risk for Adult Chronic Rhinosinusitis
- Losing Teeth May Lead to Weight Gain, Researchers Report
- American College of Cardiology, March 28-30
- Hundreds of U.S. Hospitals at Risk of Shutting Down From Medicaid Cuts
- Over 10.2 Million Grill Brushes Recalled Over Metal Bristle Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions